Now 66 patient organisations from 53 countries are members of the CML Advocates Network
The "CML Advocates Network", an international platform for patient groups supporting patients and relatives suffering from "Chronic Myeloid Leukaemia" (CML) now connects 66 organisations from 53 countries across all continents. This worldwide network offers support by sharing of best practice, information and advice for CML patient representatives. We are delighted to welcome our newest member "Thai CML Patients Group" from Thailand!
- See profile of Thai CML Patients Group
- See the list of CML groups in the Network, and our worldwide map
CML Horizons 2012: Meeting Report and Webstreams now available
The "CML Horizons 2012" conference, held in Munich on 11-13 May 2012, has again demonstrated the power of patient advocacy - and that collaboration, sharing and networking across borders is key to help patients and families affected by CML. The meeting report (PDF) as well as video streams of all plenary sessions are now available.
Welcome to our CML Education & Science Section!
Facilitating access to information and providing educational material and scientific information in a patient-friendly language to patient advocates is one of the main objectives of CML Advocates Network.
In this section you will find:
- Our research on adherence in CML: The CML Advocates Network has conducted extensive research on adherence in CML.
- Educational videos for patients, aimed to highlight the subjects of “adherence”, “side effects” and "testing and monitoring". These topics are considered relevant for nearly every CML patient. Videos are available in different languages.
- Animated patient videosAnimated patient videos that bring to life the emotional impact of CML on patients and their friends and family, in addition to their future hopes and aspirations. All stories are based on the international CML Book "Faces of Courage and Hope", an English-language book that illustrates the life of 16 CML patients from 15 countries.
- Patient-friendly summaries of the European LeukemiaNet (ELN Treatment Recommendations. Our patient summaries are available in different languages.
- CML learning programmes. At this stage you can access the EBMT CML Learning Programme devised by the European Group for Blood an Marrow Transplantation (EBMT) Nurses Group. It has been developed specifically for nurses dealing with CML patients. More programmes shall follow in the near future.
- A CML Glossary that will help you understand medical and scientific texts. It contains a list of terms commonly used in the area of CML.
We hope that you will find this section useful! If you have additional information or feedback, please make sure you contact us at info@cmladvocates.net!
1 commentsNow 65 patient organisations from 52 countries are members of the CML Advocates Network
The "CML Advocates Network", an international platform for patient groups supporting patients and relatives suffering from "Chronic Myeloid Leukaemia" (CML) now connects 65 organisations from 52 countries across all continents. This worldwide network offers support by sharing of best practice, information and advice for CML patient representatives. We are delighted to welcome our newest member "CML Tunisia"!
- See profile of CML Tunisia
- See the list of CML groups in the Network, and our worldwide map
CML Horizons 2012: 86 patient advocates from 48 countries met to "Learn, Share and Grow"
The "CML Horizons 2012" conference, held in Munich on 11-13 May 2012, was a great success. 86 representatives of leukemia patient organisations from from 48 countries participated in this global advocacy summit. It helped CML patient advocates to identify opportunities in patient advocacy and patient support, hear about newest advances in CML management, share ideas and best practices, and start building alliances across borders. CML Horizons is an independent, community-run and multi-sponsored conference, run by the CML Advocates Network and the Leukemia Patient Advocates Foundation. It has evolved from the "New Horizons" conferences 2002-2011. See more information here.
Patient-friendly summary of ELN Guidelines now available in eight languages
